Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jagsonpal Pharmaceuticals Ltd. ( (IN:JAGSNPHARM) ) has shared an update.
Jagsonpal Pharmaceuticals Ltd. has published newspaper advertisements in the English and Hindi editions of Business Standard containing extracts of its unaudited financial results for the quarter and nine-month period ended 31 December 2025, in compliance with Regulation 47 of SEBI’s Listing Obligations and Disclosure Requirements. By formally notifying the stock exchanges of this disclosure, the company is reinforcing its regulatory compliance and transparency obligations to investors and other stakeholders regarding its interim financial performance.
More about Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd. is an Indian pharmaceutical company operating in the healthcare industry, with its shares listed on both BSE and the National Stock Exchange of India under the symbol JAGSNPHARM. The company is subject to SEBI’s Listing Obligations and Disclosure Requirements, reflecting its status as a publicly traded entity in the domestic capital markets.
Average Trading Volume: 3,732
Technical Sentiment Signal: Hold
Current Market Cap: 11.64B INR
For an in-depth examination of JAGSNPHARM stock, go to TipRanks’ Overview page.